“Adjuvant topical dorzolamide or timolol with intravitreal bevacizumab for diabetic macular edema: A double-blind randomized controlled trial”, J Curr Biomed Rep, vol. 5, no. 1, pp. 14–19, Mar. 2024, doi: 10.61882/jcbior.5.1.279.